{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T02:01:34Z","timestamp":1725501694426},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T00:00:00Z","timestamp":1248998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s12031-009-9220-9","type":"journal-article","created":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T06:47:24Z","timestamp":1248936444000},"page":"17-24","source":"Crossref","is-referenced-by-count":4,"title":["Chronic Administration with Rotenone does not Enhance MPTP Neurotoxicity in C57BL\/6 Mice"],"prefix":"10.1007","volume":"41","author":[{"given":"Eriko","family":"Aoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,31]]},"reference":[{"key":"9220_CR1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","volume":"136","author":"M Alam","year":"2002","unstructured":"Alam, M., & Schmidt, W. J. (2002). Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behavioral Brain Research, 136, 317\u2013324.","journal-title":"Behavioral Brain Research"},{"key":"9220_CR2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(01)02944-4","volume":"918","author":"T Araki","year":"2001","unstructured":"Araki, T., Kumagai, T., Tanaka, K., et al. (2001). Neuroprotective effect of riluzole in MPTP-treated mice. Brain Research, 918, 176\u2013181.","journal-title":"Brain Research"},{"key":"9220_CR3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet, R., Sherer, T. B., MacKenzie, G., et al. (2000). Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nature Neuroscience, 3, 1301\u20131306.","journal-title":"Nature Neuroscience"},{"key":"9220_CR4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.20937","volume":"60","author":"J Bove","year":"2006","unstructured":"Bove, J., Zhou, C., Jackson-Lewis, V., Taylor, J., et al. (2006). Proteasome inhibition and Parkinson\u2019s disease modeling. Annals of Neurology, 60, 260\u2013264.","journal-title":"Annals of Neurology"},{"key":"9220_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H., Del Tredici, K., Rub, U., et al. (2003). Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiology of Aging, 24, 197\u2013211.","journal-title":"Neurobiology of Aging"},{"key":"9220_CR6","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"RS Burns","year":"1983","unstructured":"Burns, R. S., Chiueh, C. C., Markey, S. P., et al. (1983). A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Proceedings of the National Academy of Sciences of the United States of America, 80, 4546\u20134550.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9220_CR7","doi-asserted-by":"crossref","first-page":"15136","DOI":"10.1073\/pnas.0807581105","volume":"105","author":"WS Choi","year":"2008","unstructured":"Choi, W. S., Kruse, S. E., Palmiter, R. D., & Xia, Z. (2008). Mitochodrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proceedings of the National Academy of Sciences of the United States of America, 105, 15136\u201315141.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9220_CR8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer, W., & Przedborski, S. (2003). Parkinson\u2019s disease: Mechanisms and models. Neuron, 39, 889\u2013909.","journal-title":"Neuron"},{"key":"9220_CR9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","volume":"175","author":"R Deumens","year":"2002","unstructured":"Deumens, R., Blokland, A., & Prickaerts, J. (2002). Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Experimental Neurology, 175, 303\u2013317.","journal-title":"Experimental Neurology"},{"key":"9220_CR10","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","volume":"81","author":"HM Gao","year":"2002","unstructured":"Gao, H. M., Jiang, J., Wilson, B., et al. (2002). Microglial activation- mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: Relevance to Parkinson\u2019s disease. Journal of Neurochemistry, 81, 1285\u20131297.","journal-title":"Journal of Neurochemistry"},{"key":"9220_CR11","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","volume":"50","author":"JM Gorell","year":"1998","unstructured":"Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., & Richardson, R. J. (1998). The risk of Parkinson\u2019s disease with exposure to pesticides, farming, well water, and rural living. Neurology, 50, 1346\u20131350.","journal-title":"Neurology"},{"key":"9220_CR12","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","volume":"224","author":"RE Heikkila","year":"1984","unstructured":"Heikkila, R. E., Hess, A., & Duvoisin, R. C. (1984). Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyidine in mice. Science, 224, 1451\u20131453.","journal-title":"Science"},{"key":"9220_CR13","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","volume":"53","author":"P Jenner","year":"2003","unstructured":"Jenner, P. (2003). Oxidative stress in Parkinson\u2019s disease. Annals of Neurology, 53, S26\u2013S38.","journal-title":"Annals of Neurology"},{"key":"9220_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0163-7258(02)00301-7","volume":"97","author":"Y Kitamura","year":"2003","unstructured":"Kitamura, Y., & Nomura, Y. (2003). Stress proteins and glial functions: possible therapeutic targets for neurodegerative disorders. Pharmacology and Therapeutics, 97, 35\u201353.","journal-title":"Pharmacology and Therapeutics"},{"key":"9220_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pbb.2004.03.006","volume":"78","author":"R Kurosaki","year":"2004","unstructured":"Kurosaki, R., Muramatsu, Y., Kato, H., & Araki, T. (2004). Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson\u2019s disease. Pharmacology, Biochemistry and Behavior, 78, 143\u2013153.","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"9220_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.euroneuro.2004.05.007","volume":"15","author":"R Kurosaki","year":"2005","unstructured":"Kurosaki, R., Muramatsu, Y., Kato, H., et al. (2005). Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. European Neuropsychopharmacology, 15, 57\u201367.","journal-title":"European Neuropsychopharmacology"},{"key":"9220_CR17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0161-813X(02)00098-0","volume":"23","author":"JW Langston","year":"2002","unstructured":"Langston, J. W. (2002). Parkinson\u2019s disease: Current and future challenges. Neurotoxicology, 23, 443\u2013450.","journal-title":"Neurotoxicology"},{"key":"9220_CR18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983). Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science, 219, 979\u2013980.","journal-title":"Science"},{"key":"9220_CR19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jnnp.64.3.314","volume":"64","author":"PK Morrish","year":"1998","unstructured":"Morrish, P. K., Rakshi, J. S., Bailey, D. L., Sawle, G. V., & Brooks, D. J. (1998). Measuring the rate of progression and estimating the preclinical period of Parkinson\u2019s disease with [18F]dopa PET. Journal of Neurology, Neurosurgery and Psychiatry, 64, 314\u2013319.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"9220_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/glia.10225","volume":"42","author":"Y Muramatsu","year":"2003","unstructured":"Muramatsu, Y., Kurosaki, R., Watanabe, H., et al. (2003). Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Glia, 42, 307\u2013313.","journal-title":"Glia"},{"key":"9220_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","volume":"22","author":"CW Olanow","year":"1999","unstructured":"Olanow, C. W., & Tatton, W. G. (1999). Etiology and pathogenesis of Parkinson\u2019s disease. Annual Review of Neuroscience, 22, 123\u2013144.","journal-title":"Annual Review of Neuroscience"},{"issue":"Suppl 3","key":"9220_CR22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/ana.10566","volume":"53","author":"CW Olanow","year":"2003","unstructured":"Olanow, C. W., Schapira, A. H., & Agid, Y. (2003). Neuroprotection for Parkinson\u2019s disease:prospects and promises. Annals of Neurology, 53(Suppl 3), S1\u2013S2.","journal-title":"Annals of Neurology"},{"key":"9220_CR23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2008.07.019","volume":"296","author":"M Ookubo","year":"2008","unstructured":"Ookubo, M., Yokoyama, H., Takagi, S., Kato, H., & Araki, T. (2008). Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice. Molecular and Cellular Endocrinology, 296, 87\u201393.","journal-title":"Molecular and Cellular Endocrinology"},{"key":"9220_CR24","doi-asserted-by":"crossref","first-page":"42026","DOI":"10.1074\/jbc.M508628200","volume":"280","author":"A Panov","year":"2005","unstructured":"Panov, A., Dikalov, S., Shalbuyeva, N., et al. (2005). Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. Journal of Biological Chemistry, 280, 42026\u201342035.","journal-title":"Journal of Biological Chemistry"},{"key":"9220_CR25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0166-2236(03)00144-9","volume":"26","author":"C Perier","year":"2003","unstructured":"Perier, C., Bove, J., Vila, M., & Przedborski, S. (2003). The rotenone model of Parkinson\u2019s disease. Trends in Neurosciences, 26, 345\u2013346.","journal-title":"Trends in Neurosciences"},{"key":"9220_CR26","doi-asserted-by":"crossref","first-page":"34105","DOI":"10.1074\/jbc.M503483200","volume":"280","author":"Y Ren","year":"2005","unstructured":"Ren, Y., Liu, W., Jiang, H., Jiang, Q., & Feng, J. (2005). Selective vulnerability of dopaminergic neurons to microtubule depolymerization. Journal of Biological Chemistry, 280, 34105\u201334112.","journal-title":"Journal of Biological Chemistry"},{"key":"9220_CR27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.expneurol.2007.07.022","volume":"208","author":"AI Rojo","year":"2007","unstructured":"Rojo, A. I., Cavada, C., de Sagarra, M. R., & Cuadrado, A. (2007). Chronic inhalation of rotenone or paraquat does not induce Parkinson\u2019s disease symptoms in mice or rats. Experimental Neurology, 208, 120\u2013126.","journal-title":"Experimental Neurology"},{"key":"9220_CR28","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.tiv.2008.04.019","volume":"22","author":"Y Sai","year":"2008","unstructured":"Sai, Y., Wu, Q., Le, W., Ye, F., Li, Y., & Dong, Z. (2008). Rotenone-induced PC12 cells toxicity is caused by oxidative stress resulting from altered dopamine metabolism. Toxicology in Vitro, 22, 1461\u20131468.","journal-title":"Toxicology in Vitro"},{"key":"9220_CR29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0005-2728(01)00183-9","volume":"1506","author":"F Schuler","year":"2001","unstructured":"Schuler, F., & Casida, J. E. (2001). Functional coupling of PSST and ND1 subunits in NADH:ubiquinone oxidoreductase established by photoaffinity labeling. Biochemica et Biophysica Acta, 1506, 79\u201387.","journal-title":"Biochemica et Biophysica Acta"},{"key":"9220_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","volume":"179","author":"TB Sherer","year":"2003","unstructured":"Sherer, T. B., Kim, J. H., Betarbet, R., & Greenamyre, J. T. (2003). Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Experimental Neurology, 179, 9\u201316.","journal-title":"Experimental Neurology"},{"key":"9220_CR31","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1523\/JNEUROSCI.20-24-09207.2000","volume":"20","author":"M Thiruchelvam","year":"2000","unstructured":"Thiruchelvam, M., Richfield, E. K., Baggs, R. B., Tank, A. W., & Cory-Slecha, D. A. (2000). The nigrostriatal dopaminergic system as a preferential target of repeated exposure to combined paraquat and maneb: Implications for Parkinson\u2019s disease. Journal of Neuroscience, 20, 9207\u20139214.","journal-title":"Journal of Neuroscience"},{"key":"9220_CR32","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00702-008-0019-6","volume":"115","author":"H Yokoyama","year":"2008","unstructured":"Yokoyama, H., Takagi, S., Watanabe, Y., Kato, H., & Araki, T. (2008). Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice. Journal of Neural Transmission, 115, 831\u2013842.","journal-title":"Journal of Neural Transmission"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-009-9220-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-009-9220-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-009-9220-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:19:21Z","timestamp":1559441961000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-009-9220-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,31]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["9220"],"URL":"https:\/\/doi.org\/10.1007\/s12031-009-9220-9","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,31]]}}}